skin cancer
Akoya Biosciences Licenses Early-Stage Melanoma Test From NeraCare
The exclusive license agreement builds on an existing research collaboration between the companies to develop assays for skin cancer using Akoya's immunofluorescence platform.
ASHG: Herpesvirus Integrated in Human Genome Increases Skin Cancer Risk, UK Biobank Study Finds
Premium
Researchers showed that inherited chromosomally integrated HHV-6 (ici-HHV-6) is associated with a threefold increase in basal cell carcinoma risk.
Castle Biosciences Q3 Revenues up 39 Percent
The company saw growth across its melanoma, squamous cell carcinoma, Barrett's esophagus, and pharmacogenomics tests.
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
New Cancer Susceptibility Genes Identified in Germline Genetic Variation Study
Researchers tracked down six genes with ties to increased or decreased cancer risk in a study involving nearly 864,500 European ancestry individuals with or without cancer.